Search research articles
Contact Us
Filters
Showing results (1-10 of 4) with videos related to
Page
of 1
Sort By:
Journal of Interventional Cardiology
|
March 18, 2008
Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications
James Fitts, Peter Ver Lee, Patricia Hofmaster, et al.
The American Journal of Cardiology
|
January 12, 2020
Acute Kidney Recovery in Patients Who Underwent Transcatheter Versus Surgical Aortic Valve Replacement (from the Northern New England Cardiovascular Disease Study Group)
Rony Lahoud, David W Butzel, Anahita Parsee, et al.
The Journal of Invasive Cardiology
|
November 11, 2003
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results
Kenneth W Mahaffey, Bruce E Lewis, Nancy M Wildermann, et al.
The New England Journal of Medicine
|
November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
Laura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 4) with videos related to
Sort By:
Page
of 1
Journal of Interventional Cardiology
|
March 18, 2008
Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications
James Fitts, Peter Ver Lee, Patricia Hofmaster, et al.
The American Journal of Cardiology
|
January 12, 2020
Acute Kidney Recovery in Patients Who Underwent Transcatheter Versus Surgical Aortic Valve Replacement (from the Northern New England Cardiovascular Disease Study Group)
Rony Lahoud, David W Butzel, Anahita Parsee, et al.
The Journal of Invasive Cardiology
|
November 11, 2003
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results
Kenneth W Mahaffey, Bruce E Lewis, Nancy M Wildermann, et al.
The New England Journal of Medicine
|
November 18, 2014
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
Laura Mauri, Dean J Kereiakes, Robert W Yeh, et al.
Page
of 1